Abbott announced that the FDA has approved its RealTime HBV assay for measuring the amount of hepatitis B virus (HBV) in human plasma or serum from individuals chronically infected with HBV. The ...

For cancer patients with chronic hepatitis B virus (HBV) infection, who receive cytotoxic chemotherapy, HBV reactivation is a well-described complication, which may result in varying degrees of liver ...

Assay can be used with the Abbott m2000 system to understand response to treatment. Abbott received approval from the FDA to market the Abbott RealTime HBV assay for quantitation of HBV in plasma or ...

BURLINGTON, N.C.--(BUSINESS WIRE)--LabCorp® (NYSE: LH), a leading global life sciences company, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for the ...

Real-time PCR or quantitative PCR (Polymerase Chain Reaction) is an advancement of the standard PCR technique, which enables continuous monitoring of the reaction and collection of data in real time.

Occult HCV infection is defined by the existence of an HCV-RNA-positive strand in the serum, lymphoid cells (peripheral blood mononuclear cells [PBMCs]) and/or the liver, and the detection of a ...

Background and Aim: Long-term lamivudine treatment for chronic hepatitis B virus (HBV) infection induces the emergence of lamivudine resistant HBV YMDD mutant strains. The aim of the present study was ...